SEC Form D · Amendment · filed December 6, 2017
Carmell Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
James J. Hart · Hershey, PAExecRandolph Hubbell · Pittsburgh, PAExec · DirectorJames F. Jordan · Pittsburgh, PADirectorStephanie W. Kladakis · Pittsburgh, PAExecDonna Godward · Pittsburgh, PAExecDavid W. Anderson · Pittsburgh, PADirectorRichard Upton · Pittsburgh, PADirectorAlex R. Duncan · Lexington, MAExecMichael Meyers · Los Angeles, CADirectorJames Connolly · Los Angeles, CAExec · DirectorChristian R. Cortis · Lexington, MAExecJustin Fallon · Los Angeles, CADirectorJay Venkatesan · Los Angeles, CAExecEvan R. Kearns · Lexington, MADirectorAndrew W. Dym · New York, NYExecDavid W. Schiff · New York, NYDirectorJoseph W. Schottland · New York, NYDirectorMax Lin · MENLO PARK, CAExec · DirectorJim Momtazee · MENLO PARK, CAExecMark Bisso · HOUSTON, TXExecAndrew J. Duffy · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗